Produkty 2097-85-0

CAS 2097-85-0 występuje w naszej ofercie pod nazwami: (5Alpha)-4,4-Dimethylcholestan-3-one, (5a)-4,4-Dimethylcholestan-3-one. Oferty producentów: TRC. Dostępne opakowania: 10mg, 25mg, 50mg.

(5Alpha)-4,4-Dimethylcholestan-3-one
TRC
  • opakowanie: 10mg, 25mg
  • Warianty: 2
Zobacz produkt
(5a)-4,4-Dimethylcholestan-3-one
TRC
  • opakowanie: 50mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one (CAS 2097-85-0) to związek chemiczny o wzorze sumarycznym C29H50O i masie molowej 414.7 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one. InChIKey: QVGZIULKEGAMON-NLTWXGGESA-N.

Dane identyfikacyjne
Wzór sumarycznyC29H50O
Masa molowa414.7 g/mol
Nazwa IUPAC(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
InChIKeyQVGZIULKEGAMON-NLTWXGGESA-N
SMILESC[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CCC(=O)C4(C)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: (5a)-4,4-Dimethylcholestan-3-one, (5Alpha)-4,4-Dimethylcholestan-3-one, 4,4-Dimethylcholestan-3-one, 4,4-Dimethyl-5-a-cholestane-3-one; 4,4-Dimethyl-5a-cholestan-3-one, 4,4-Dimethylcholestan-3-one #, QVGZIULKEGAMON-NLTWXGGESA-N, Cholestan-3-one, 4,4-dimethyl-
Izomery (ten sam wzór sumaryczny)
(3S,8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol C29H50O
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H50O
(3S,5R,10S,13R,14R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol C29H50O
(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H50O